healthXL Global Gathering Attendee List for Thursday 29th May
Global Gathering Dublin · HealthXL Global Gathering | Dublin | September 2019 #HXLGG Welcome...
Transcript of Global Gathering Dublin · HealthXL Global Gathering | Dublin | September 2019 #HXLGG Welcome...
Novartis | Dublin
September 4th, 2019
Global Gathering
Dublin
See who attended
Tom ParsonsChief Product Officer &
Cofounder
HealthXL
Pedro LopezHead, Product Lifecycle
Services & Novartis Global
Service Center Dublin
Novartis
#HXLGGHealthXL Global Gathering | Dublin | September 2019
Welcome Address
Martin Kelly CEO & Cofounder
HealthXL
Chandana FitzgeraldChief Medical Officer
HealthXL
The HealthXL Digital Health Evidence Report
Deep dive into the report
The HealthXL Vision
One True Source for Digital Health
Clinical Trial Optimization
Marie Ennis-O'ConnorOwner
Health Care Social Media
Monitor
Kuldeep Singh RajputFounder & CEO
Biofourmis
Tyler PugsleyVice President of
Life Sciences
Medable
Francesca WuttkeChief Digital Officer
Almirall
Dermot KennyGlobal Head
Data Operations
Novartis
#HXLGGHealthXL Global Gathering | Dublin | September 2019
Keynote
Keynote
Panel
Derek RichardsChief Science Officer
SilverCloud Health
Jonas DussUS CEO
Kaia Health
Abhishek Shah CEO
Wellthy Therapeutics
Christoph RuedigPartner
AlbionVC
Digital Therapeutics: What next?
Brian FlatlyBusiness Strategy &
Engagement Director S3
Connected Health
Sahil KirpekarHead of Business
Developement
Europe Otsuka
Pharmaceutical
#HXLGGHealthXL Global Gathering | Dublin | September 2019
Keynote
Panel
Keynote
Lisa SuennenLead, Digital & Technology Business,
Manatt Ventures Managing Partner,
Venture Valkyrie Previously GE Ventures
Jeremy SohnGlobal Head, Digital Development and
Business Development & Licensing,
Novartis
Fireside Chat
#HXLGGHealthXL Global Gathering | Dublin | September 2019
Bill TarantoPresident
Merck Global
Health Innovation
Fund
Robert GarberPartner
7wire Ventures
Ask the Investor Top 5 Current Investments in Digital Health
• AliveCor has dropped Kardiaband Apple Watch Accessory - what could this mean for a start-
up? Are exploratory partnerships risky for start-ups because a large tech company could just
recreate their products and sideline them easily.
• Tempus , Doctolib recent investments - seriously big numbers that are only getting bigger.
Are we progressing on all other fronts to justify this investment?
• Halo doc investment; Cure fit investments - east vs. west what are the differences
• Livongo IPO: how to achieve as an SME, what it means for the DTx industry
• Babylon new investment: despite skepticism, AI continues to be invested in.
#HXLGG
What We Do